Transforming Multichannel Content Distribution

Share this article:

Click here to register

Date:Wednesday, September 24
Time: 1:00 PM ET / 10:00 AM PT

Creating, approving, and distributing promotional content is one of the greatest challenges in commercial life science. With multiple external partners and disconnected systems supporting a highly iterative process, it is slow and costly to deliver new content through all communications channels. Because content updates and withdrawals take longer, it also poses a greater compliance risk. To eliminate these pitfalls, many organizations are transforming their end-to-end processes by bringing content management and multichannel distribution together in the cloud.

This webinar will discuss how to:

    1. Improve the speed and efficiency of multichannel distribution
    2. Reduce compliance risk across all channels with real-time content updates, withdrawals and expiry
    3. Reduce cost throughout the end-to-end content-management process

Speaker:  

Paul Shawah, Vice President, Product Marketing








Sponsored by:

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Webcasts

Delighting Your Customer through Multichannel Customer Engagement

Today's life sciences customers expect service delivered on their terms. They want the convenience of email, phone, web, and face-to-face - all personalized, all coordinated. The typical experience they receive as a consumer.

The New World of the Customer Experience - Not Your Daddy's Call ...

In this webcast, we will talk about how TrialCard's Customer Experience Center has become the focal point of our business - from inbound support for pharmacies, physicians, and patients through teledetailing and whitespace management to insurance verification and marketing research.

Green light, or go slow: What FDA's new draft guidance means ...

While not the last word on the subject, the agency's latest social media guidance was a good step forward. This informative webcast is designed to dissect the guidance and help brand directors and communication managers, whether currently engaging in social media or looking to do ...